Abstract
The purpose of this study was to determine the promotional role of estrogen and progestin in the development of radiation-induced mammary tumors. To eliminate the effects of endogenous ovarian hormones on tumor promotion, all rats were ovariectomized immediately after the initiation by irradiation with 2.6 Gy γ-rays at day 21 of lactation, and were divided into 3 groups. For the control experiment, rats were implanted with a cholesterol pellet 1 month after the irradiation. Only one rat developed a fibroadenoma (4.3% mammary tumor incidence) during the 1 year period of the implantation. In the other two groups, chlormadinone acetate (CMA) to increase progestin level or diethylstilbestrol (DES) to increase estrogenic activity were administered, respectively, as tumor promoters for 1 year. Treatment with CMA did not significantly increase the incidence of mammary tumors as compared with the controls. However, administration of DES resulted in a significantly higher mammary tumor incidence (79.3%) than control treatment. Compared with cholesterol administration, DES treatment caused an increase in prolactin concentration in serum (5-fold), and reduction of estradiol-17β concentration (22% of control). These results suggest that DES ia a potent effective promoter for tumorigenesis of radiation-initiated mammary cells, but CMA is not. DES may act directly on the irradiated mammary cells by binding to ER, and indirectly by stimulating prolactin secretion from the pituitary glands.
Similar content being viewed by others
References
Inano H, Suzuki K, Onoda M, Yamanouchi H: Susceptibility of fetal, virgin, pregnant and lactating rats for the induction of mammary tumors by gamma rays. Radiat Res 145: 708–713, 1996
Suzuki K, Ishii-Ohba H, Yamanouchi H, Wakabayashi K, Takahashi M, Inano H: Susceptibility of lactating rat mammary glands to gamma-ray irradiation-induced tumorigenesis. Int J Cancer 56: 413–417, 1994
Yamanouchi H, Ishii-Ohba H, Suzuki K, Onoda M, Wakabayashi K, Inano H: Relationship between stages of mammary development and sensitivity to gamma-ray irradiation in mammary tumorigenesis in rats. Int J Cancer 60: 230–234, 1995
Inano H, Yamanouchi H, Suzuki K, Onoda M, Wakabayashi K: Estradiol-17β as an initiation modifier for radiationinduced mammary tumorigenesis of rats ovariectomized before puberty. Carcinogenesis 16: 1871–1877, 1995
Tucker HA, Reece RP:Nucleic acid content of rat mammary glands during post-lactational involution. Proc Soc Expt Biol Med 112: 1002–1004, 1963
Walker NI, Bennett RE, Kerr JFR: Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 185: 19–32, 1989
Stranger R, Li F, Saurer S, Burkhardt A, Furus RR: Apoptotic cell death and tissue remodeling in mouse mammary gland involution. Development 115: 49–58, 1992
Guenette RS, Corbeil HB, Leger J, Wong K, Mezl V, Mooibroek M, Tenniswood M: Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endocrinol 12: 47–60, 1994
Rothschild TC, Boylan ES, Calhoon RE, Vonderhaar BK: Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res 47: 4508–4516, 1987
Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 61: 244–278, 1990
Watanabe G, Taya K, Sasamoto S: Dynamics of ovarian inhibin secretion during the oestrous cycles of rats. J Endocrinol 126: 151–157, 1990
Johnson RB, Nakamura RM, Libby RM: Simplified Scatchard plot assay for estrogen receptor in human breast tumor. Clin Chem 21: 1715–1730, 1975
Johnson RB, Nakamura RM: Simplified Scatchard plot assay for progesterone receptor in breast cancer: Comparison with single-point and multipoint assay. Clin Chem 24: 1170–1176, 1978
Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci USA 51: 660–672, 1949
Holtzman S, Stone JP, Shellabarger CJ: Radiation-induced mammary carcinogenesis in virgin, pregnant, lactating and postlactating rats. Cancer Res 42: 50–53, 1982
Inano H, Suzuki K, Ishii-Ohba H, Ikeda K, Wakabayashi K: Pregnancy-dependent initiation in tumorigenesis of Wistar rat mammary glands by 60Co-irradiation. Carcinogenesis 12: 1085–1090, 1991
Dauvois S, Labrie F: Androstenedione and androst-5-ene-3β, 17β-diol stimulate DMBA-induced rat mammary tumors. Role of aromatase. Breast Cancer Res Treat 13: 61–69, 1989
Amenomori Y, Chen CL, Meites J: Serum prolactin levels in rats during different reproductive states. Endocrinology 86: 506–510, 1970
Inano H, Suzuki K, Ishii-Ohba H, Yamanouchi H, Takahashi M, Wakabayashi K: Promotive effects of diethylstilbestrol, its metabolite (Z,Z-dienestrol) and a stereoisomer of the metabolite (E,E-dienestrol) in tumorigenesis of rat mammary glands pregnancy-dependently initiated with radiation. Carcinogenesis 14: 2157–2163, 1993
Oliveira MC, Spritzer P, Poy M, Coronel AX, Dahlem N, Moraes JT, Barbosa-Coutinho LM: Progestin effects on prolactin secretion and on immunoreactive prolactin cells in estradiol-treated ovariectomized rats. Hormone Metab Res 25: 600–602, 1993
Maurer RA: Estradiol regulates the transcription of the prolactin gene. J Biol Chem 257: 2133–2136, 1982
Zinder O, Hamosh M, Fleck TRC, Scow RO: Effect of prolactin on lipoprotein lipase mammary gland and adipose tissue of rats. Am J Physiol 226: 744–748, 1974
Flint DJ, Clegg RA, Knight CH: Effects of prolactin, progesterone and ovariectomy on metabolic activities and insulin receptors in the mammary gland and adipose tissue during extended lactation in the rat. J Endocrinol 102: 231–236, 1984
Pazos P, Lanari C, Meiss R, Charreau EH, Pasqualini CD: Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice. Breast Cancer Res Treat 20: 133–138, 1991
Pazos P, Lanari C, Elizalde P, Montecchia F, Charreau EH, Molinolo AA: Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice. Carcinogenesis 19: 529–531, 1998
Butler C, Hill H: Chlormadinone acetate as oral contraceptive. Lancet 1(7606): 1116–1119, 1969
Nischan P, Ebeling K: Oral contraceptive containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic. A correlation analysis. Int J Cancer 34: 671–674, 1984
Declercq G, Bedes P: The effects of chlormadinone acetate upon estradiol uptake by the rat mammary glands in organ culture. Am J Obstet Gynecol 118: 1050–1053, 1974
Beck P, Molarkey WB: Serum prolactin concentrations in women treated with chlormadinone acetate. Am J Obstet Gynecol 124: 578–581, 1976
Tominaga T, Kitamura M, Saito T, Itoh I: Effects of hexestrol, medroxyprogesterone acetate and chlormadinone acetate on 7,12-dimethylbenz(a)anthracene-induced rat mammary cancer in relation to estrogen receptor. Gann 72: 604–609, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inano, H., Suzuki, K., Onoda, M. et al. Comparative effect of chlormadinone acetate and diethylstilbestrol as promoters in mammary tumorigenesis of rats irradiated with γ-rays during lactation. Breast Cancer Res Treat 53, 153–160 (1999). https://doi.org/10.1023/A:1006149608475
Issue Date:
DOI: https://doi.org/10.1023/A:1006149608475